Australia
| ACN | 000132865 |
|---|---|
| Status | Registered |
| Legal form | APTY |
| Registered | 1954-06-03 |
| Register | Australian Securities and Investments Commission |
| Buyer | Contract | Value | Published |
|---|---|---|---|
| National Blood Authority | Supply of Hemlibra | A$353.2M | 2020-11-04 |
| National Blood Authority | Procurement of Imported Plasma and Recombinant Products (IPRP) – Hemlibra (emicizumab) | A$317.7M | 2025-07-18 |
| Department of Health and Aged Care | Purchase for the National Medical Stockpile | A$15.8M | 2023-04-27 |